Difference between revisions of "Example orders for Sipuleucel-T (Provenge) in prostate cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "{{:Editing test page 2}}<br>" to "") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].''' | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 9: | Line 9: | ||
===Example order set #1=== | ===Example order set #1=== | ||
| − | *[[Sipuleucel-T (Provenge)]] 1 bag IV over 60 minutes once per day on days 1, 15, 29. | + | *[[Sipuleucel-T (Provenge)]] 1 bag IV over 60 minutes once per day on days 1, 15, 29. Prior to administration, gently agitate bag of sipuleucel-T to resuspend. Use standard tubing without a filter. |
| − | ====Supportive | + | ====Supportive therapy==== |
| − | *Acetaminophen (Tylenol) 650 mg PO once 30 minutes prior to infusion | + | *Acetaminophen (Tylenol) 650 mg PO once; 30 minutes prior to infusion |
| − | *Diphenhydramine (Benadryl) 25 to 50 mg PO once 30 minutes prior to infusion | + | *Diphenhydramine (Benadryl) 25 to 50 mg PO once; 30 minutes prior to infusion |
Monitoring/precautions: | Monitoring/precautions: | ||
| Line 20: | Line 20: | ||
Nursing: | Nursing: | ||
| − | *Patients without central lines: insert peripheral IV before therapy. | + | *Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete. |
| − | *Patients with central lines: access the central venous access device before therapy. | + | *Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete. |
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:42, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Sipuleucel-T (Provenge)
Published regimens and references can be found on the prostate cancer page.
Example order set #1
- Sipuleucel-T (Provenge) 1 bag IV over 60 minutes once per day on days 1, 15, 29. Prior to administration, gently agitate bag of sipuleucel-T to resuspend. Use standard tubing without a filter.
Supportive therapy
- Acetaminophen (Tylenol) 650 mg PO once; 30 minutes prior to infusion
- Diphenhydramine (Benadryl) 25 to 50 mg PO once; 30 minutes prior to infusion
Monitoring/precautions:
- Confirm that patient has not had fevers or chills prior to receiving acetaminophen so that staff can property monitoring for side effects from sipuleucel-T infusion.
- Observe patient for at least 30 minutes after each infusion in case the patient develops an acute infusion reaction.
Nursing:
- Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete.
- Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete.